A single RGD-containing sequence present within an epidermal growth factor-like repeat of the short arms of laminin is shown by peptide inhibition to block integrin receptors recognizing a latent cell-binding site of laminin. Based on proteolysis data it is proposed that masking occurs by folding of the globular domain IVa over the cell-binding site in the adjacent rod-like structures of laminin A chain.Basement membrane; Cell attachment; Integrin; Proteolytic fragment; Synthetic peptide
I~RODUCTIONFragment P 1 generated from laminin by pepsin treatment was the first domain of the protein shown to be involved in cellular interactions [1,2]. Various cells have been found which bind fragment Pl with high affinity (KD -l-4 nM) to an apparently homogenous class of receptors [3-51. It was later shown that this binding site is latent both within laminin and within a larger PI-related fragment produced by cleavage with elastase [6], The Pl fragment (about 200 kDa) comprises the inner rod-like structure of the short arms of laminin and contains some 28 EGF-like repeats contributed by the A, Bl and B2 chains of laminin [7-91. Its A chain segment also possesses the only RGD (ArgGly-Asp) sequence present in mouse laminin [9]. Similar sequences are involved in cell binding to several other proteins including fibronectin, vitronectin and collagens [lo]. Here, we show by peptide and antibody inhibition and by proteolytic inactivation that the laminin RGD sequence very likely corresponds to the latent cell-binding site identified previously [6], and is recognized by cellular receptors of the integrin family.
EXPERIMENTALThe mouse EHS tumor laminin-nidogen complex ill] and its large tryptic fragment Tl (121 were prepared as previously described. Both Abbreviations: EGF, epidermal growth factor; EHS, EngelbrethHolm-Swarm tumor; HPLC, high performance liquid chromatography; TLCK, tosyl lysyl chloromethane components were cleaved in 0.1 M glycine-HCl, pH 1.9 with pepsin (24 h, 25"C, enzyme-substrate ratio 1:iOO) to generate fragment PI which was then purified on a molecular sieve fl2]. Some small peptides in the pepsin digest were bound to heparin-Sepharose (Pharmacia) equilibrated in 0.1 M NaCl, 0.05 M Tris-HCl, pH 7.4 and eluted with 0.5 M NaCl. This material was separated into 25 distinct peaks by reversed phase HPLC and individual peptides were identified by Edman degradation [13]. Trypsin inactivation of PI some synthetic peptides was performed at 37°C in 0.2 M NH4HCOa (enzyme-substrate ratio 1:lOO) and the reaction was stopped by adding TLCK. Laminin fragment Pl was also isolated from human placenta [14]. Human plasma fibronectin (Behringwerke) was further purified on haparin-Sepharose. Synthetic peptides GRGDS (Promega) and ROES (Peninsula) were from commercial sources. Other RGD-cont~~ng peptides (see fig. 1) were synthesized according to sequences of mouse [P] and human fl5] laminin A chain, mouse laminin Bl chain 1161 and mouse nidogen (171 and kindly suppiied by Drs J. Knolle, S. Henke (Hoechst AG) and W. Sttiber (Behri...